The market size for Wound Care Management Devices in Europe was worth USD 5.43 billion in 2022 and estimated to be growing at a CAGR of 3.62%, to reach USD 6.49 billion by 2027.
Europe is the second-largest market for wound care management devices. The shift in the business environment and increased patient needs has resulted from investment in research & development in the wound care sector for the products that are easier to use, more comfortable, and provide quick wound healing with less pain.
The wound care management devices markets in Europe are largely driven by an increasingly aging population, growing in purchasing power due to higher disposable incomes, and rising incidence of chronic diseases. Factors impelling the wound care management devices products include the minimum need of bed capacity in hospitals and shifting inclination towards homecare therapies that improve healing and reduce hospital time.
However, the market is constrained by challenges, such as costly procedures and a lack of proper reimbursements.
This research report on the Europe Wound Care Management Devices Market has been segmented & sub-segmented into the below categories:
By Type of Wound:
By End User:
Based on geography, Germany and France are expected to grow at the highest CAGR in the forecast period.
Notable companies operating in the European wound care management devices market are Coloplast A/S, Baxter International Inc., Hollister Inc., Mölnlycke Health Care, 3M Company, Covidien PLC, Ethicon Inc., Derma Sciences Inc., Convatec Healthcare B.S.A.R.L, Acelity L.P/, and Smith & Nephew.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com